lobbying_activities: 1195351

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1195351	4ff12899-c02d-444b-a702-159c02e900ec	Q4	EISAI INC.	400321512	EISAI INC.	2011	fourth_quarter	PHA	Prescription Drug User Fee Act reauthorization. FDA-DEA issues. Drug shortages issues.	HOUSE OF REPRESENTATIVES,SENATE		750000	0	0	2012-01-19T12:54:34-05:00